Abstract:Twenty‐seven novel l‐tryptophan derivatives with strong antioxidant potential were designed and synthesized according to the reported l‐tryptophan derivatives with submicromolar butyrylcholinesterase inhibitory activity. Compounds 3a‐18 and 3b‐1 with the strongest inhibitory activity, also exhibited extraordinary antioxidant activity, inhibitory activity against β‐amyloid1–42 self‐aggregation, and low cell toxicity. Alzheimer's disease (AD) is a multifactorial neurological disease, and the multitarget directed ligand (MTDL) strategy may be an effective approach to delay its progression. Based on this strategy, 27 derivatives of l‐tryptophan, 3a‐1–3d‐1, were designed, synthesized, and evaluated for their biological activity. Among them, IC50 (inhibitor concentration resulting in 50% inhibitory activity) values of compounds 3a‐18 and 3b‐1 were 0.58 and 0.44 μM for human serum butyrylcholinesterase (hBuChE), respectively, and both of them exhibited more than 30‐fold selectivity for human serum acetylcholinesterase. Enzyme kinetics studies showed that these two compounds were mixed inhibitors of hBuChE. In addition, these two derivatives possessed extraordinary antioxidant activity in OH radical scavenging and oxygen radical absorption capacity fluorescein assays. Meanwhile, these compounds could also prevent β‐amyloid (Aβ) self‐aggregation and possessed low toxicity on PC12 and AML12 cells. Molecular modeling studies revealed that these two compounds could interact with the choline binding site, acetyl binding site, and peripheral anionic site to exert submicromolar BuChE inhibitory activity. In the vitro blood–brain barrier permeation assay, compounds 3a‐18 and 3b‐1 showed enough blood–brain barrier permeability. In drug‐likeness prediction, compounds 3a‐18 and 3b‐1 showed good gastrointestinal absorption and a low risk of human ether‐a‐go‐go‐related gene toxicity. Therefore, compounds 3a‐18 and 3b‐1 are potential multitarget anti‐AD lead compounds, which could work as powerful antioxidants with submicromolar selective inhibitory activity for hBuChE as well as prevent Aβ self‐aggregation.

Design, Synthesis and Anti-Alzheimer Properties of Dimethylaminomethyl-Substituted Curcumin Derivatives

Design, Synthesis and Biological Evaluation of 2-Styryl-5-hydroxy-4-pyrone Derivatives and Analogues As Multiple Functional Agents with the Potential for the Treatment of Alzheimer's Disease.

Design, Synthesis and Evaluation of Rivastigmine and Curcumin Hybrids As Site-Activated Multitarget-Directed Ligands for Alzheimer's Disease Therapy.

Design, Synthesis, and Biological Evaluation of Curcumin Analogues As Multifunctional Agents for the Treatment of Alzheimer’s Disease

Syntheses and Evaluation of Asymmetric Curcumin Analogues As Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease

Design and Synthesis of Dimethylaminomethyl-Substituted Curcumin Derivatives: Potent Anti-Inflammatory, Anti-Oxidant, and Radioprotection Activity, Improved Aqueous Solubility Compared with Curcumin

Design, Synthesis, and Evaluation of Multitarget-Directed Ligands Against Alzheimer's Disease Based on the Fusion of Donepezil and Curcumin.

Design and Synthesis of Dimethylaminomethyl-Substituted Curcumin Derivatives/analogues: Potent Antitumor and Antioxidant Activity, Improved Stability and Aqueous Solubility Compared with Curcumin.

Novel coumarin derivatives as multifunctional anti-AD agents: Design, synthesis, X-ray crystal structure and biological evaluation

Design, Synthesis, and Biological Evaluation of Scutellarein Carbamate Derivatives As Potential Multifunctional Agents for the Treatment of Alzheimer's Disease

Design, Synthesis and Biological Evaluation of Multifunctional Tacrine-Curcumin Hybrids As New Cholinesterase Inhibitors with Metal Ions-Chelating and Neuroprotective Property

Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids As Multifunctional Drug Candidates Against Alzheimer’s Disease

Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer's Disease.

Design, Synthesis and Evaluation of Novel Bivalent Β-Carboline Derivatives As Multifunctional Agents for the Treatment of Alzheimer's Disease.

Design, Synthesis and Biological Evaluation of New Coumarin-Dithiocarbamate Hybrids As Multifunctional Agents for the Treatment of Alzheimer's Disease

Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease

Synthesis and biological evaluation of 3-(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer's disease agents.

Multifunctional Coumarin Derivatives: Monoamine Oxidase B (MAO-B) Inhibition, Anti-Β-amyloid (aβ) Aggregation and Metal Chelation Properties Against Alzheimer's Disease.

A Comparison of the Location in Membranes of Curcumin and Curcumin-Derived Bivalent Compounds with Potential Neuroprotective Capacity for Alzheimer's Disease.

Design, Synthesis, and Evaluation of Salicyladimine Derivatives As Multitarget-Directed Ligands Against Alzheimer's Disease.